Cargando…
Mechanisms of Cardiotoxicity Associated with Tyrosine Kinase Inhibitors in H9c2 Cells and Mice
Autores principales: | Bouitbir, J, Alshaikhali, A, Panajatovic, M, Abegg, V, Paech, F, Krähenbühl, S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Radcliffe Cardiology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312714/ https://www.ncbi.nlm.nih.gov/pubmed/32612693 http://dx.doi.org/10.15420/ecr.2020.15.1.PO10 |
Ejemplares similares
-
Statins and Insulin Resistance
por: Sanvee, GM, et al.
Publicado: (2020) -
Role of PGC-1-alpha-associated Mitochondrial Biogenesis in Statin-induced Myotoxicity
por: Panajatovic, M, et al.
Publicado: (2020) -
Hepatocellular Toxicity Associated with Tyrosine Kinase Inhibitors: Mitochondrial Damage and Inhibition of Glycolysis
por: Paech, Franziska, et al.
Publicado: (2017) -
Mitochondrial Toxicity Associated with Imatinib and Sorafenib in Isolated Rat Heart Fibers and the Cardiomyoblast H9c2 Cell Line
por: Bouitbir, Jamal, et al.
Publicado: (2022) -
Young Investigator Award: Compound A, a Ginger Extract, Significantly Reduces Pressure Overload-induced Systolic Heart Failure in Mice
por: Kawase, Yuto, et al.
Publicado: (2021)